Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Feb;11(2):203-8.
doi: 10.1111/j.1365-2125.1981.tb01125.x.

Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations

Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations

J Barclay et al. Br J Clin Pharmacol. 1981 Feb.

Abstract

1 The effect of inhaled salbutamol following a maximally effective dose of theophylline given by intravenous infusion was determined in 12 patients with chronic bronchitis. 2 An initial single intravenous dose study was performed to estimate each patient's theophylline kinetics and to identify those patients who would respond to theophylline. 3 Pulmonary function was assessed at hourly intervals during four to five incremental steady state theophylline infusions over the concentration range 5-25 mg/l. 4 Inhaled salbutamol (400 micrograms) was administered after the maximum effect from theophylline had been achieved or when theophylline concentrations reached 25 mg/l without maximum effect: pulmonary function was again assessed. 5 Ten patients achieved a further significant improvement in pulmonary function after salbutamol: in five, predicted values for FVC were exceeded. 6 Patients with chronic bronchitis may benefit from the combination of theophylline and salbutamol if steady state theophylline concentrations of 15-20 mg/l are achieved.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1974 Oct;16(4):691-700 - PubMed
    1. Br J Clin Pharmacol. 1978 Jan;5(1):45-50 - PubMed
    1. N Engl J Med. 1978 Feb 16;298(7):363-7 - PubMed
    1. Lung. 1978;154(4):273-82 - PubMed
    1. Br J Clin Pharmacol. 1978 Dec;6(6):499-503 - PubMed

LinkOut - more resources